Splice Bio Revenue and Competitors
Estimated Revenue & Valuation
- Splice Bio's estimated annual revenue is currently $7.4M per year.
- Splice Bio's estimated revenue per employee is $155,000
Employee Data
- Splice Bio has 48 Employees.
- Splice Bio grew their employee count by 45% last year.
Splice Bio's People
| Name | Title | Email/Phone |
|---|
Splice Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.4M | 41 | N/A | N/A | N/A |
#2 | $0.9M | 6 | N/A | N/A | N/A |
#3 | $5.9M | 38 | N/A | N/A | N/A |
#4 | $47M | 303 | 18% | N/A | N/A |
#5 | $9.5M | 61 | 11% | N/A | N/A |
#6 | $46.7M | 301 | 25% | N/A | N/A |
#7 | $1.7M | 11 | -8% | N/A | N/A |
#8 | $3.7M | 24 | -11% | N/A | N/A |
#9 | $4.2M | 27 | 13% | N/A | N/A |
#10 | $5.3M | 34 | 6% | N/A | N/A |
What Is Splice Bio?
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company's platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted. www.splice.bio.
keywords:N/A
N/A
Total Funding
48
Number of Employees
$7.4M
Revenue (est)
45%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Splice Bio News
BMN 351 was developed using familiar chemistry and superior biology, by targeting a novel, upstream, splice enhancer site demonstrating...
List of the Top Key Players of Fiber Optic Splice Closures (FOSC) Market: Thermo Fisher Scientific, Roche, Bio-rad, Qiagen, Agilent, Bioer,...
Other Companies in Barcelona
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.4M | 48 | 0% | N/A |
#2 | $10.4M | 48 | 37% | N/A |
#3 | $5M | 48 | 7% | N/A |
#4 | $5.7M | 49 | 7% | N/A |
#5 | $12.7M | 49 | 11% | N/A |